Janssen Vaccines & Prevention B.v.

This study tested an experimental vaccine to prevent serious lung infections caused by RSV in adults aged 60 and older. Over 25,000 participants received either the vaccine or a placebo. The goal was to see if the vaccine could reduce cases of RSV-related lower respiratory tract …

This study tested a new universal flu vaccine in 170 healthy adults aged 18 to 45. The goal was to see if the vaccine is safe and triggers an immune response against many flu strains. Researchers gave either the vaccine or a placebo and monitored side effects and antibody levels.